Wells Fargo’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.4K | Sell |
17,692
-1,131
|
|
||||
|
2025
Q1 | $49.5K | Buy |
18,823
+416
|
|
||||
|
2024
Q4 | $65.2K | Buy |
18,407
+9,663
|
|
||||
|
2024
Q3 | $39.9K | Sell |
8,744
-347
|
|
||||
|
2024
Q2 | $39.5K | Buy |
9,091
+503
|
|
||||
|
2024
Q1 | $43.1K | Buy |
8,588
+1,154
|
|
||||
|
2023
Q4 | $46.6K | Buy |
7,434
+1,699
|
|
||||
|
2023
Q3 | $40.8K | Sell |
5,735
-6,234
|
|
||||
|
2023
Q2 | $122K | Buy |
11,969
+11,856
|
|
||||
|
2023
Q1 | $1.02K | Buy |
113
+48
|
|
||||
|
2022
Q4 | $466 | Buy |
65
+1
|
|
||||
|
2022
Q3 | $0 | Sell |
64
-2
|
|
||||
|
2022
Q2 | $0 | Buy |
66
+5
|
|
||||
|
2022
Q1 | $0 | Buy |
61
+1
|
|
||||
|
2021
Q4 | $0 | Hold |
60
|
|
||||
|
2021
Q3 | $0 | Hold |
60
|
|
||||
|
2021
Q2 | $0 | Sell |
60
-2,136
|
|
||||
|
2021
Q1 | $15K | Sell |
2,196
-17,784
|
|
||||
|
2020
Q4 | $105K | Buy |
19,980
+3,738
|
|
||||
|
2020
Q3 | $121K | Buy |
16,242
+1,645
|
|
||||
|
2020
Q2 | $108K | Buy |
14,597
+14,576
|
|
||||
|
2020
Q1 | $0 | Sell |
21
-179
|
|
||||
|
2019
Q4 | $1K | Buy |
+200
|
|
||||
|
2019
Q3 | – | Sell |
-411
|
|
||||
|
2019
Q2 | $1K | Sell |
411
-3,779
|
|
||||
|
2019
Q1 | $13K | Buy |
4,190
+5
|
|
||||
|
2018
Q4 | $16K | Sell |
4,185
-25
|
|
||||
|
2018
Q3 | $25K | Sell |
4,210
-14,872
|
|
||||
|
2018
Q2 | $108K | Buy |
19,082
+14,818
|
|
||||
|
2018
Q1 | $53K | Buy |
4,264
+4,064
|
|
||||
|
2017
Q4 | $2K | Buy |
+200
|
|